Abstract
Flavins are active components of many enzymes. In most cases, riboflavin (vitamin B2) as a coenzyme represents the catalytic part of the holoenzyme. Riboflavin is an amphiphatic molecule and allows a large variety of different interactions with the enzyme itself and also with the substrate. A great number of active riboflavin analogs can readily be synthesized by chemical methods and, thus, a large number of possible inhibitors for many different enzyme targets is conceivable. As mammalian and especially human biochemistry depends on flavins as well, the target of the inhibiting flavin analog has to be carefully selected to avoid unwanted effects. In addition to flavoproteins, enzymes, which are involved in the biosynthesis of flavins, are possible targets for anti-infectives. Only a few flavin analogs or inhibitors of flavin biosynthesis have been subjected to detailed studies to evaluate their biological activity. Nevertheless, flavin analogs certainly have the potential to serve as basic structures for the development of novel anti-infectives and it is possible that, in the future, the urgent need for new molecules to fight multiresistant microorganisms will be met.
Similar content being viewed by others
References
Bacher A (1991) Riboflavin kinase and FAD synthetase. In: Muller F (ed) Chemistry and biochemistry of flavoenzymes. CRC, Boca Raton, FL, pp 349–370
Bacher A et al (1997) Biosynthesis of riboflavin: lumazine synthase and riboflavin synthase. Methods Enzymol 280:389–399
Bacher A et al (2001) Biosynthesis of riboflavin. Vitam Horm 61:1–49
Bandrin SV, Beburov M, Rabinovich PM, Stepanov AI (1979) Riboflavin auxotrophs of Escherichiacoli. Genetika 15:2063–2065
Bardos TJ (1974) Antimetabolites: molecular design and mode of action. Top Curr Chem 52:63–98
Bereswill S, Hinkelmann S, Kist M, Sander A (1999) Molecular analysis of riboflavin synthesis genes in Bartonellahenselae and use of the ribC gene for differentiation of Bartonella species by PCR. J Clin Microbiol 37:3159–3166
Burgess C, O’Connell-Motherway M, Sybesma W, Hugenholtz J, van Sinderen D (2004) Riboflavin production in Lactococcuslactis: potential for in situ production of vitamin-enriched foods. Appl Environ Microbiol 70:5769–5777
Cecchini G, Kearney EB (1980) Uptake and binding of riboflavin by membrane vesicles of Bacillussubtilis. J Supramol Struct 13:93–100
Cecchini G, Perl M, Lipsick J, Singer TP, Kearney EB (1979) Transport and binding of riboflavin by Bacillussubtilis. J Biol Chem 254:7295–7301
Chen J et al (2005) A high-throughput screen utilizing the fluorescence of riboflavin for identification of lumazine synthase inhibitors. Anal Biochem 338:124–130
Choi KP, Kendrick N, Daniels L (2002) Demonstration that fbiC is required by Mycobacteriumbovis BCG for coenzyme F(420) and FO biosynthesis. J Bacteriol 184:2420–2428
Chu CK, Bardos TJ (1977) Synthesis and inhibition analysis of 2(4)-imino-4(2)-amino-2,4-dideoxyriboflavin, a dual antagonist of riboflavin and folinic acid. J Med Chem 20:312–314
Coats JH, Li GP, Kuo MS, Yurek DA (1989) Discovery, production, and biological assay of an unusual flavenoid cofactor involved in lincomycin biosynthesis. J Antibiot (Tokyo) 42:472–474
Cushman M, Mihalic JT, Kis K, Bacher A (1999) Design and synthesis of 6-(6-d-ribitylamino-2,4-dihydroxypyrimidin-5-yl)-1-hexyl phosphonic acid, a potent inhibitor of lumazine synthase. Bioorg Med Chem Lett 9:39–42
Cushman M, Yang D, Kis K, Bacher A (2001) Design, synthesis, and evaluation of 9-d-ribityl-1,3,7-trihydro-2,6,8-purinetrione, a potent inhibitor of riboflavin synthase and lumazine synthase. J Org Chem 66:8320–8327
Cushman M et al (2002) Design, synthesis, and evaluation of 6-carboxyalkyl and 6-phosphonoxyalkyl derivatives of 7-oxo-8-ribitylaminolumazines as inhibitors of riboflavin synthase and lumazine synthase. J Org Chem 67:5807–5816
Cushman M, Sambaiah T, Jin G, Illarionov B, Fischer M, Bacher A (2004) Design, synthesis, and evaluation of 9-d-ribitylamino-1,3,7,9-tetrahydro-2,6,8-purinetriones bearing alkyl phosphate and alpha,alpha-difluorophosphonate substituents as inhibitors of tiboflavin synthase and lumazine synthase. J Org Chem 69:601–612
Dahl SG, Sylte I, Ravna AW (2004) Structures and models of transporter proteins. J Pharmacol Exp Ther 309:853–860
Daniels L, Bakhiet N, Harmon K (1985) Widespread distribution of a 5-deazaflavin cofactor in actinomycetes and related bacteria. Syst Appl Microbiol 6:12–17
DiMarco AA, Bobik TA, Wolfe RS (1990) Unusual coenzymes of methanogenesis. Annu Rev Biochem 59:355–394
Echt S, Bauer S, Steinbacher S, Huber R, Bacher A, Fischer M (2004) Potential anti-infective targets in pathogenic yeasts: structure and properties of 3,4-dihydroxy-2-butanone 4-phosphate synthase of Candidaalbicans. J Mol Biol 341:1085–1096
Edmondson D, Ghisla S (1999) Flavoenzyme structure and function. Approaches using flavin analogues. Methods Mol Biol 131:157–179
Eirich LD, Vogels GD, Wolfe RS (1978) Proposed structure for coenzyme F420 from Methanobacterium. Biochemistry 17:4583–4593
Eirich LD, Vogels GD, Wolfe RS (1979) Distribution of coenzyme F420 and properties of its hydrolytic fragments. J Bacteriol 140:20–27
Fischer M, Bacher A (2005) Biosynthesis of flavocoenzymes. Nat Prod Rep 22:324–350
Fuller TE, Mulks MH (1995) Characterization of Actinobacilluspleuropneumoniae riboflavin biosynthesis genes. J Bacteriol 177:7265–7270
Fuller TE, Thacker BJ, Mulks MH (1996) A riboflavin auxotroph of Actinobacilluspleuropneumoniae is attenuated in swine. Infect Immun 64:4659–4664
Gerhardt S et al (2002a) The structural basis of riboflavin binding to Schizosaccharomycespombe6,7-dimethyl-8-ribityllumazine synthase. J Mol Biol 318:1317–1329
Gerhardt S et al (2002b) Studies on the reaction mechanism of riboflavin synthase: X-ray crystal structure of a complex with 6-carboxyethyl-7-oxo-8-ribityllumazine. Structure (Camb) 10:1371–1381
Ghisla S, Massey V (1986) New flavins for old: artificial flavins as active site probes of flavoproteins. Biochem J 239:1–12
Ghisla S, Mayhew SG (1976) Identification and properties of 8-hydroxyflavin-adenine dinucleotide in electron-transferring flavoprotein from Peptostreptococcuselsdenii. Eur J Biochem 63:373–390
Graham DW, Brown JE, Ashton WT, Brown RD, Rogers EF (1977) Anticoccidial riboflavine antagonists. Experientia 33:1274–1276
Graupner M, White RH (2001) Biosynthesis of the phosphodiester bond in coenzyme F(420) in the methanoarchaea. Biochemistry 40:10859–10872
Green JM, Nichols BP, Matthews RG (1996) Folate biosynthesis, reduction, and polyglutamylation. In: Neidhardt FC (ed) Escherichiacoli and Salmonella: cellular and molecular biology. ASM, Washington, DC, pp 665–673
Gusarov II et al (1997) Riboflavin biosynthetic genes in Bacillus amyloliquefaciens: primary structure, organization and regulation of activity. Mol Biol (Mosk) 31:446–453
Juri N, Kubo Y, Kasai S, Otani S, Kusunose M, Matsui K (1987) Formation of roseoflavin from 8-amino- and 8-methylamino-8-demethyl-d-riboflavin. J Biochem (Tokyo) 101:705–711
Kasai S et al (1978) Anti-riboflavin activity of 8N-alkyl analogues of roseoflavin in some Gram-positive bacteria. J Nutr Sci Vitaminol (Tokyo) 24:339–350
Kasai S, Yamanaka S, Wang SC, Matsui K (1979) Anti-riboflavin activity of 8-O-alkyl derivatives of riboflavin in some Gram-positive bacteria. J Nutr Sci Vitaminol (Tokyo) 25:289–298
Kearney EB, Goldenberg J, Lipsick J, Perl M (1979) Flavokinase and FAD synthetase from Bacillussubtilis specific for reduced flavins. J Biol Chem 254:9551–9557
Kisker C, Schindelin H, Rees DC (1997) Molybdenum-cofactor-containing enzymes: structure and mechanism. Annu Rev Biochem 66:233–267
Klinke S, Zylberman V, Vega DR, Guimaraes BG, Braden BC, Goldbaum FA (2005) Crystallographic studies on decameric Brucella spp. lumazine synthase: a novel quaternary arrangement evolved for a new function? J Mol Biol 353:124–137
Kuo MS, Yurek DA, Coats JH, Li GP (1989) Isolation and identification of 7,8-didemethyl-8-hydroxy-5-deazariboflavin, an unusual cosynthetic factor in streptomycetes, from Streptomyceslincolnensis. J Antibiot (Tokyo) 42:475–478
Kurth R, Paust J, Hähnlein W (1996) Vitamins, chapter 7. In: Ullmann’s encyclopedia of industrial chemistry. VCH, Weinheim, pp 521–530
Ladenstein R et al (1988) Heavy riboflavin synthase from Bacillussubtilis. Crystal structure analysis of the icosahedral beta 60 capsid at 3.3 A resolution. J Mol Biol 203:1045–1070
Lambooy JP (1951) Activity of 6,7-diethyl-9-(d-1′-ribityl)-isoalloxazine for Lactobacilluscasei. J Biol Chem 188:459–462
Lambooy JP (1975) Biological activities of analogs of riboflavin. Plenum, New York, NY
Lambooy JP, Shaffner CS (1977) Utilization of analogues of riboflavin by the riboflavin-deficient chick embryo. J Nutr 107:245–250
Lee CY, Szittner RB, Miyamoto CM, Meighen EA (1993) The gene convergent to luxG in Vibriofischeri codes for a protein related in sequence to RibG and deoxycytidylate deaminase. Biochim Biophys Acta 1143:337–339
Lee CY, O’Kane DJ, Meighen EA (1994) Riboflavin synthesis genes are linked with the lux operon of Photobacteriumphosphoreum. J Bacteriol 176:2100–2104
Liao DI, Calabrese JC, Wawrzak Z, Viitanen PV, Jordan DB (2001a) Crystal structure of 3,4-dihydroxy-2-butanone 4-phosphate synthase of riboflavin biosynthesis. Structure (Camb) 9:11–18
Liao DI, Wawrzak Z, Calabrese JC, Viitanen PV, Jordan DB (2001b) Crystal structure of riboflavin synthase. Structure (Camb) 9:399–408
Lin JW, Chao YF, Weng SF (2001) Riboflavin synthesis genes ribE, ribB, ribH, ribA reside in the lux operon of Photobacteriumleiognathi. Biochem Biophys Res Commun 284:587–595
Logvinenko EM, Shavlovskii GM, Koltun LV (1972) Preparation and properties of riboflavin-dependent mutants of Pichiaguilliermondii Wickerham yeasts. Mikrobiologiia 41:1103–1104
Manstein DJ, Pai EF (1986) Purification and characterization of FAD synthetase from Brevibacteriumammoniagenes. J Biol Chem 261:16169–16173
Mao Y, Varoglu M, Sherman DH (1999) Molecular characterization and analysis of the biosynthetic gene cluster for the antitumor antibiotic mitomycin C from Streptomyceslavendulae NRRL 2564. Chem Biol 6:251–263
Matsui K, Juri N, Kubo Y, Kasai S (1979) Formation of roseoflavin from guanine through riboflavin. J Biochem (Tokyo) 86:167–175
Matsui K et al (1982) Riboflavin production by roseoflavin-resistant strains of some bacteria. Agric Biol Chem 46:2003–2008
Meining W, Mortl S, Fischer M, Cushman M, Bacher A, Ladenstein R (2000) The atomic structure of pentameric lumazine synthase from Saccharomycescerevisiae at 1.85 A resolution reveals the binding mode of a phosphonate intermediate analogue. J Mol Biol 299:181–197
Miller SM (2004) A new role for an old cofactor. Nat Struct Mol Biol 11:497–498
Mironov AS et al (2002) Sensing small molecules by nascent RNA: a mechanism to control transcription in bacteria. Cell 111:747–756
Morgunova E et al (2005) Crystal structure of lumazine synthase from Mycobacteriumtuberculosis as a target for rational drug design: binding mode of a new class of purinetrione inhibitors. Biochemistry 44:2746–2758
Mortl S, Fischer M, Richter G, Tack J, Weinkauf S, Bacher A (1996) Biosynthesis of riboflavin. Lumazine synthase of Escherichiacoli. J Biol Chem 271:33201–33207
Muller F (1991) Chemistry and biochemistry of flavoproteins. CRC, Boca Raton, FL
Murthy YV, Massey V (1997) Syntheses and applications of flavin analogs as active site probes for flavoproteins. Methods Enzymol 280:436–460
Nakajima H (1993) Tuberculosis: a global emergency. World Health 46:3
Nielsen P, Rauschenbach P, Bacher A (1986) Preparation, properties, and separation by high-performance liquid chromatography of riboflavin phosphates. Methods Enzymol 122:209–220
Odur A (1994) Flavin derivatives as anti-viral agents. Patent application, Radopath, PCT/GB94/02292
O’Farrell PA, Walsh MA, McCarthy AA, Higgins TM, Voordouw G, Mayhew SG (1998) Modulation of the redox potentials of FMN in Desulfovibriovulgarisflavodoxin: thermodynamic properties and crystal structures of glycine-61 mutants. Biochemistry 37:8405–8416
Oltmanns O, Lingens F (1967) Isolation of riboflavin-deficient mutants of Saccharomycescerevisiae. Z Naturforsch B 22:751–754
Otani S, Takatsu M, Nakano M, Kasai S, Miura R (1974) Letter: roseoflavin, a new antimicrobial pigment from Streptomyces. J Antibiot (Tokyo) 27:86–87
Otani S, Kasai S, Matsui K (1980) Isolation, chemical synthesis, and properties of roseoflavin. Methods Enzymol 66:235–241
Perkins J, Pero J (2002) Biosynthesis of riboflavin, biotin, folic acid, and cobalamin. In: Sonenshein A, Hoch J, Losick R (eds) Bacillussubtilis and its closest relatives: from genes to cells. ASM, Washington, DC, pp 271–286
Persson K, Schneider G, Jordan DB, Viitanen PV, Sandalova T (1999) Crystal structure analysis of a pentameric fungal and an icosahedral plant lumazine synthase reveals the structural basis for differences in assembly. Protein Sci 8:2355–2365
Platz M (2003) Flavin N-oxides: new anti-cancer agents and pathogen eradication agents. Patent application, Ohio State University, PCT/US2003/014673
Purwantini E, Gillis TP, Daniels L (1997) Presence of F420-dependent glucose-6-phosphate dehydrogenase in Mycobacterium and Nocardia species, but absence from Streptomyces and Corynebacterium species and methanogenic Archaea. FEMS Microbiol Lett 146:129–134
Reuke B, Korn S, Eisenreich W, Bacher A (1992) Biosynthetic precursors of deazaflavins. J Bacteriol 174:4042–4049
Ritsert K, Huber R, Turk D, Ladenstein R, Schmidt-Base K, Bacher A (1995) Studies on the lumazine synthase/riboflavin synthase complex of Bacillussubtilis: crystal structure analysis of reconstituted, icosahedral beta-subunit capsids with bound substrate analogue inhibitor at 2.4 A resolution. J Mol Biol 253:151–167
Schwogler A, Carell T (2000) Toward catalytically active oligonucleotides: synthesis of a flavin nucleotide and its incorporation into DNA. Org Lett 2:1415–1418
Shinkai S, Kameoka K, Honda N, Ueda K, Manabe O, Lindsey J (1986) Spectral and reactivity studies of roseoflavin analogs: correlation between reactivity and spectral parameters. Bioorg Chem 14:119–133
Singer TP, Edmondson DE (1974) 8 alpha-substituted flavins of biological importance. FEBS Lett 42:1–14
Stahmann KP, Revuelta JL, Seulberger H (2000) Three biotechnical processes using Ashbyagossypii, Candidafamata, or Bacillussubtilis compete with chemical riboflavin production. Appl Microbiol Biotechnol 53:509–516
Stover CK et al (2000) A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis. Nature 405:962–966
Stratton CW (2000) Mechanisms of bacterial resistance to antimicrobial agents. J Med Liban 48:186–198
Sybesma W, Burgess C, Starrenburg M, van Sinderen D, Hugenholtz J (2004) Multivitamin production in Lactococcuslactis using metabolic engineering. Metab Eng 6:109–115
Vitreschak AG, Rodionov DA, Mironov AA, Gelfand MS (2002) Regulation of riboflavin biosynthesis and transport genes in bacteria by transcriptional and translational attenuation. Nucleic Acids Res 30:3141–3151
Vitreschak AG, Rodionov DA, Mironov AA, Gelfand MS (2003) Regulation of the vitamin B12 metabolism and transport in bacteria by a conserved RNA structural element. RNA 9:1084–1097
Vitreschak AG, Rodionov DA, Mironov AA, Gelfand MS (2004) Riboswitches: the oldest mechanism for the regulation of gene expression? Trends Genet 20:44–50
Walsh C et al (1978) Chemical and enzymatic properties of riboflavin analogues. Biochemistry 17:1942–1951
Zhang X, Meining W, Fischer M, Bacher A, Ladenstein R (2001) X-ray structure analysis and crystallographic refinement of lumazine synthase from the hyperthermophile Aquifexaeolicus at 1.6 A resolution: determinants of thermostability revealed from structural comparisons. J Mol Biol 306:1099–1114
Zhang X et al (2003) A structure-based model of the reaction catalyzed by lumazine synthase from Aquifexaeolicus. J Mol Biol 328:167–182
Zylberman V, Craig PO, Klinke S, Braden BC, Cauerhff A, Goldbaum FA (2004) High order quaternary arrangement confers increased structural stability to Brucella sp. lumazine synthase. J Biol Chem 279:8093–8101
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mack, M., Grill, S. Riboflavin analogs and inhibitors of riboflavin biosynthesis. Appl Microbiol Biotechnol 71, 265–275 (2006). https://doi.org/10.1007/s00253-006-0421-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00253-006-0421-7